Silence Therapeutics plc Share Price
Stocks
SLN
US82686Q1013
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Cboe BZX
17:33:25 25/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 11.23 USD | +0.09% |
|
-7.87% | +84.87% |
| Market Cap | 511M 676M 594M 560M 956M 64.85B 963M 6.72B 2.6B 33B 2.54B 2.48B 107B | P/E 2026 * |
-21.1x | P/E 2027 * | -16.9x |
|---|---|---|---|---|---|
| Enterprise Value | 378M 500M 439M 414M 707M 47.96B 712M 4.97B 1.93B 24.41B 1.88B 1.84B 79.43B | EV / Sales 2026 * |
1,172x | EV / Sales 2027 * | 449x |
| Free-Float |
69.35% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SLN | Delayed | |
CBOE
| SLN | Real-time | |
|
Tradegate
| XRP2 | Real-time | |
|
Deutsche Boerse AG
| XRP2 | Delayed | |
|
Börse Stuttgart
| XRP2 | Delayed | |
|
Boerse Muenchen
| XRP2 | Real-time |
Last Transcript: Silence Therapeutics plc
| 1 day | -0.85% | ||
| 1 week | -8.32% | ||
| Current month | -17.33% | ||
| 1 month | -18.18% | ||
| 3 months | +11.85% | ||
| 6 months | +104.48% | ||
| Current year | +83.96% |
| 1 week | 11.04 |  | 12.5 |
| 1 month | 11.04 | | 15.28 |
| Current year | 4.19 | | 17.58 |
| 1 year | 4.19 | | 17.58 |
| 3 years | 1.97 | | 27.72 |
| 5 years | 1.97 | | 27.72 |
| 10 years | 1.97 | | 35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Iain Ross
CEO | Chief Executive Officer | 72 | 30/11/2025 |
Rhonda Hellums
DFI | Director of Finance/CFO | 54 | 31/01/2022 |
Curtis Rambaran
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
David Lemus
BRD | Director/Board Member | 63 | 20/06/2018 |
Iain Ross
CHM | Chairman | 72 | 31/12/2003 |
Tim McInerney
BRD | Director/Board Member | 65 | 04/05/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 06/07/26 | Sell | 865,112 | 0.6105% | |||
| 02/01/26 | Free | Chief Financial Officer | 375,000 | 0.2646% | ||
| 02/01/26 | Free | Director | 90,000 | 0.0635% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.85% | -8.32% | +123.70% | +12.87% | 676M | |
| -0.14% | +4.33% | +9.88% | +31.73% | 48.01B | |
| -1.15% | +2.14% | +54.02% | +34.46% | 45.27B | |
| +0.83% | +3.33% | +10.29% | +90.43% | 40.93B | |
| +5.49% | +9.08% | +389.98% | +606.07% | 42.84B | |
| -0.62% | -1.61% | +5.30% | +46.02% | 29.6B | |
| -0.92% | +0.21% | +25.75% | +150.75% | 17.32B | |
| -0.46% | +1.20% | +26.78% | +41.32% | 15.34B | |
| -1.81% | -4.34% | - | - | 15.15B | |
| +0.90% | +6.35% | +7.05% | - | 14.84B | |
| Average | +0.13% | -0.25% | +72.53% | +126.71% | 27B | |
| Weighted average by Cap. | +0.55% | +1.52% | +83.38% | +155.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 322K 426K 375K 353K 603K 40.91M 608K 4.24M 1.64M 20.82M 1.6M 1.57M 67.76M | 751K 992K 873K 823K 1.4M 95.23M 1.41M 9.87M 3.83M 48.47M 3.72M 3.64M 158M |
| Net income | -42.14M -55.7M -48.99M -46.18M -78.8M -5.35B -79.41M -554M -215M -2.72B -209M -205M -8.85B | -71.01M -93.86M -82.56M -77.83M -133M -9.01B -134M -934M -362M -4.59B -352M -345M -14.92B |
| Net Debt | -133M -176M -155M -146M -249M -16.89B -251M -1.75B -678M -8.59B -661M -646M -27.97B | -174M -230M -202M -191M -325M -22.08B -328M -2.29B -887M -11.24B -864M -845M -36.57B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/09/26 | US$11.22 | 0.00% | 175,159 |
| 24/09/26 | US$11.22 | -2.52% | 691,390 |
| 23/09/26 | US$11.51 | -6.35% | 876,993 |
| 22/09/26 | US$12.29 | +0.33% | 382,051 |
| 21/09/26 | US$12.25 | +0.41% | 665,750 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SLN Stock
Select your edition
All financial news and data tailored to specific country editions
